Metraipolis › archive › dc_b0ef5374efa0
Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary… — Europe PMC PMID:39164637
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/39164637
- DOI
- 10.1186/s12879-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-09T23:09:55.782Z
- SHA-256 of the archived text
24f200134741a1e154b579f377f8882a9187a3714e8eced89110fd57144bb543- Stable URL of this page
https://metraipolis.com/documento/dc_b0ef5374efa0
How to cite
Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary… — Europe PMC PMID:39164637 — Europe PMC (en), https://europepmc.org/article/MED/39164637 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b0ef5374efa0 (Metraipolis archive dc_b0ef5374efa0, sha256 24f200134741a1e154b579f377f8882a9187a3714e8eced89110fd57144bb543)
BibTeX
@misc{dcb0ef5374efa0,
title = {Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary… — Europe PMC PMID:39164637},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/39164637},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b0ef5374efa0; sha256 24f200134741a1e154b579f377f8882a9187a3714e8eced89110fd57144bb543},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39164637. Agents can read the archived copy with the MCP tool read_document.